We used immunohistochemistry to detect FGFR1 and FGFR3 protein levels in ependymomas and pilocytic astrocytomas, and evaluated the relationship between protein expression levels, clinical features and selected genetic alterations. The gene discussed is FGFR3; the disease is pilocytic astrocytoma.